TIDMCREO

RNS Number : 4162B

Creo Medical Group PLC

06 June 2019

Creo Medical Group plc

("Creo" or the "Company")

Results of Annual General Meeting

Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that all resolutions put to shareholders at the Company's Annual General Meeting held earlier today were duly passed.

Contacts

 
 Creo Medical Group plc 
 Richard Rees (CFO)                                                    +44 (0)129 160 6005 
 
 Cenkos Securities                                                     +44 (0)20 7397 8900 
 Stephen Keys / Mark Connelly (NOMAD) 
 Michael Johnson / Russell Kerr (Sales) 
 
 Walbrook PR Ltd                           Tel: +44 (0)20 7933 8780 or creo@walbrookpr.com 
 Paul McManus                                                     Mob: +44 (0)7980 541 893

About Creo Medical

Creo Medical, founded in 2003, is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. The Company's mission is to improve patient outcomes by applying microwave and RF energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical advanced energy platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides clinicians with flexible, accurate and controlled surgical solutions.

The Company's strategy is to bring its CROMA platform to market through a suite of medical devices which the Company has designed, initially for the emerging field of GI therapeutic endoscopy, an area with high unmet needs. The CROMA platform will be developed further for bronchoscopy and laparoscopy procedures. The Company believes its technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option of treatment.

For more information about Creo Medical please see our website, investors.creomedical.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGUNUURKAANRAR

(END) Dow Jones Newswires

June 06, 2019 08:23 ET (12:23 GMT)

Creo Medical (LSE:CREO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Creo Medical Charts.
Creo Medical (LSE:CREO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Creo Medical Charts.